HORIZON THERAPEUTICS PLC (HZNP)

IE00BQPVQZ61 - Common Stock

116.3  +0.05 (+0.04%)

After market: 116.34 +0.04 (+0.03%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
2.2B
69.26%		3.226B
46.63%		3.629B
12.48%		3.881B
6.94%
EBITDA
YoY % growth
764.7M
104.03%		907.249M
18.64%		1.12B
23.48%		1.442B
28.72%
EBIT
YoY % growth
485.2M
252.62%		553.498M
14.08%		729.833M
31.86%		1.307B
79.08%
Operating Margin
22.05%17.16%20.11%33.68%
EPS
YoY % growth
3.82
91.96%		4.81
25.92%		4.87
1.25%		4.63
-5.01%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q3 / 23 Q4 / 23 Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24
EPS
Q2Q % growth		1.24
-0.72%
Revenue
Q2Q % growth		987.18M
6.68%
EBITDA
Q2Q % growth		399.87MN/AN/AN/AN/A
EBIT
Q2Q % growth		337.67M
88.01%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2023
Q2Q % growth		 1.20
12.15%		1.050.1513.95%
Q1 2023
Q2Q % growth		 0.83
-38.06%		1.14-0.31-27.35%
Q4 2022
Q2Q % growth		 1.21
-14.18%		1.110.108.82%
Q3 2022
Q2Q % growth		 1.25
-28.57%		1.030.2221.50%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q2 2023
Q2Q % growth		 944.959M
7.82%		885.04M59.919M6.77%
Q1 2023
Q2Q % growth		 832.059M
-6.01%		920.33M-88.271M-9.59%
Q4 2022
Q2Q % growth		 942.029M
-7.14%		941.38M649K0.07%
Q3 2022
Q2Q % growth		 925.359M
-10.77%		905.78M19.579M2.16%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -14.76% 0% -17.11%
Revenue0% -4.34% 0% -4.27%